Tag: Multiple Sclerosis
Standing Frame Program Can Up Motor Function in Progressive MS
Motor function increased significantly but not to degree considered a priori as clinically meaningful
Increased Cancer Risk Seen in Multiple Sclerosis Patients
Cancer risk up for MS patients versus non-MS controls, especially in respiratory, urinary, CNS organs
Cognitive Consequences Worse for Pediatric-Onset Multiple Sclerosis
Patients with POMS have more rapid reduction in information-processing efficiency over time
Model Explores How Statins Alter Multiple Sclerosis Outcomes
Loss of brain volume reduced in patients taking simvastatin independent of effect on cholesterol level
Recommendations Developed for Pediatric Multiple Sclerosis Trials
Biological rationale exists for using treatments proven efficacious in adults with MS for pediatric MS
Thresholds Found for Unilateral Optic Nerve Lesions in MS
Intereye differences for retinal nerve fiber layer and macular ganglion cell + inner plexiform layer useful
AAN: Oral BTK Inhibitor Superior to Placebo in Multiple Sclerosis
Fewer enhancing lesions seen in weeks 12 to 24 for 75 mg evobrutinib once daily versus placebo
Significant Number of Referred Patients Misdiagnosed With MS
At MS referral centers, almost one in five new patients have been incorrectly diagnosed with the disease
African-Americans With ALS Survive Longer Than Caucasians
Difference no longer significant when outcome is death or tracheostomy and invasive ventilation
Cortical Lesions in Multiple Sclerosis Tracked With 7.0-T MRI
Development of cortical lesions surpassed that of white matter lesions, linked to neurologic disability
